Milestone Pharmaceuticals Ownership | Who Owns Milestone Pharmaceuticals?

Overview Forecast RevenueFinancials Chart

Milestone Pharmaceuticals Ownership Summary

Milestone Pharmaceuticals is owned by 51.43% institutional investors, 3.36% insiders, and 45.21% retail investors. Adage capital partners gp is the largest institutional shareholder, holding 10.51% of MIST shares. Simplify Propel Opportunities ETF is the top mutual fund, with 3.33% of its assets in Milestone Pharmaceuticals shares.

MIST Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Milestone Pharmaceuticals	51.43%	3.36%	45.21%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Adage capital partners gp	6.98M	10.51%	$13.95M
Blackrock	4.97M	9.91%	$6.56M
Propel bio management	5.12M	7.72%	$10.25M
Orbimed advisors	3.22M	4.85%	$6.44M
Morgan stanley	2.97M	4.47%	$5.94M
Simplify asset management	2.83M	4.27%	$5.67M
Millennium management	2.70M	4.08%	$6.38M
Rtw investments, lp	2.51M	3.78%	$5.01M
Pathstone	1.00M	1.51%	$2.00M
Sphera funds management	820.00K	1.24%	$1.64M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Propel bio management	5.12M	10.26%	$10.25M
Lion point capital, lp	658.55K	7.48%	$1.32M
Amh equity	231.67K	0.58%	$463.34K
Boxer capital management	666.67K	0.42%	$1.33M
Sphera funds management	820.00K	0.35%	$1.64M
Orbimed advisors	3.22M	0.15%	$6.44M
Affinity asset advisors	666.67K	0.12%	$1.33M
Simplify asset management	2.83M	0.10%	$5.67M
Cascades capital asset management	77.33K	0.07%	$154.67K
Rtw investments, lp	2.51M	0.06%	$5.01M

Top Buyers

Holder	Shares	% Assets	Change
Adage capital partners gp	6.98M	0.02%	6.98M
Propel bio management	5.12M	10.26%	3.33M
Orbimed advisors	3.22M	0.15%	3.22M
Morgan stanley	2.97M	0.00%	2.15M
Simplify asset management	2.83M	0.10%	1.84M

Top Sellers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	-	-	-4.05M
Nantahala capital management	-	-	-1.45M
Alta fundamental advisers	-	-	-1.40M
Bml capital management	-	-	-1.14M
Velan capital investment management lp	-	-	-650.00K

New Positions

Holder	Shares	% Assets	Change	Value
Adage capital partners gp	6.98M	0.02%	6.98M	$13.95M
Orbimed advisors	3.22M	0.15%	3.22M	$6.44M
Pathstone	1.00M	0.01%	1.00M	$2.00M
Sphera funds management	820.00K	0.35%	820.00K	$1.64M
Affinity asset advisors	666.67K	0.12%	666.67K	$1.33M

Sold Out

Holder	Change
Qube research	-194.00
Ica group wealth management	-200.00
Jpmorgan chase	-3.27K
Citadel advisors	-3.50K
Advisor group	-6.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	66	46.67%	34,138,461	213.66%	51	19.08%	43	115.00%	5	-37.50%
Jun 30, 2025	49	4.26%	11,823,806	13.72%	17	7.25%	22	4.76%	9	-18.18%
Mar 31, 2025	48	-4.00%	11,814,084	-51.88%	17	1.30%	21	-12.50%	13	-7.14%
Dec 31, 2024	49	16.67%	24,552,980	-14.38%	37	1.98%	24	71.43%	14	75.00%
Sep 30, 2024	41	-	28,647,040	-5.08%	43	1.20%	13	-	8	33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Simplify Propel Opportunities ETF	2.83M	3.33%	1.84M
Biotech Growth Ord	474.28K	0.89%	-333.41K
BlackRock Credit Strategies Instl	231.56K	0.43%	-29.79K
LUNIS Biotech Growth Opp Fd I a	26.90K	0.05%	-
WEALTHGATE Biotech Fund Inst	26.90K	0.05%	26.90K
SPDR® S&P® International Small Cap ETF	18.73K	0.02%	-
Fidelity Nasdaq Composite Index	17.96K	0.02%	-
Dimensional Global Core Equity USD Acc	5.87K	0.01%	-
Dimensional Global Small Coms USD Acc	5.02K	0.01%	5.00
Dimensional World Equity GBP Acc	3.65K	0.01%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 01, 2022	Bharucha David	Chief Medical Officer	Buy	$14.58K
Dec 05, 2022	Bharucha David	Chief Medical Officer	Buy	$32.83K
Oct 19, 2022	Wills Robert James	-	Buy	$73.95K
Oct 20, 2022	Pasternak Richard C	-	Buy	$52.00K
Oct 20, 2022	Liebert Debra K.	-	Buy	$52.90K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q3	-	-

MIST Ownership FAQ

Who Owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals shareholders are primarily institutional investors at 51.43%, followed by 3.36% insiders and 45.21% retail investors. The average institutional ownership in Milestone Pharmaceuticals's industry, Biotech Stocks , is 45.22%, which Milestone Pharmaceuticals exceeds.

Who owns the most shares of Milestone Pharmaceuticals?

Milestone Pharmaceuticals’s largest shareholders are Adage capital partners gp (6.98M shares, 10.51%), Blackrock (4.97M shares, 9.91%), and Propel bio management (5.12M shares, 7.72%). Together, they hold 28.14% of Milestone Pharmaceuticals’s total shares outstanding.

Does Blackrock own Milestone Pharmaceuticals?

Yes, BlackRock owns 9.91% of Milestone Pharmaceuticals, totaling 4.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.56M$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Milestone Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Propel bio management is Milestone Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 10.26% of its assets in 5.12M Milestone Pharmaceuticals shares, valued at 10.25M$.

Who is the top mutual fund holder of Milestone Pharmaceuticals shares?

Simplify Propel Opportunities ETF is the top mutual fund holder of Milestone Pharmaceuticals shares, with 3.33% of its total shares outstanding invested in 2.83M Milestone Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools